Mar 31, 2014

Farmak JSC confirmed its leading position in the Ukrainian retail market of medicinal products

According to the results of 2013, the Ukrainian Pharmaceutical Company Farmak remains to be the leader of the domestic retail market of medicinal products with the market share of 4.71%. As compared to 2012, the sales growth of the pharmaceutical manufacturer amounted 11.46% in hryvnias.

This data was reported by Sergii Ishchenko, Director of Proxima Research Company, at the 9^th Annual Analytical Forum “Ukrainian Pharmaceutical Market – 2014” organized by Morion Company.

Back to the News

Previous Next

More news

Farmak has started exporting to Jordan

The Farmak Group of Companies has started exporting medicines to Jordan. A systemic corticosteroid in the form of an injection suspension was delivered to the country in the Middle East. The medicine is used to treat dermatological diseases, rheumatic diseases, allergic conditions and other diseases. Jordan has become the 61st country on the Farmak’s e...

Dec 10, 2024

Farmak exhibited its line of medicines in International...

The leader of the Ukrainian pharmaceutical market*, Farmak participated in one of most prestigious global events of the pharmaceutical industry – CPHI 2024 on October 8-10, 2024, in Milan, Italy. This year, the exhibition united over 2400 exhibitors and 62 thousand visitors of over 166 countries of the world, as well as over 150 expert […]

Oct 18, 2024

A new Chief Financial Officer has joined Farmak

A leader in the Ukrainian pharmaceutical market*, Farmak has strengthened the top management with a new Chief Financial Officer. It is Mr Serhii Plichko, who has over 15 years of experience in finance, logistics, and operations. Mr Serhii Plichko will be responsible for the operation and improvement of the financial systems, the optimization of the […...

Oct 11, 2024